Health
GW team to play a role in Sanofi COVID-19 vaccine clinical trial – News-Medical.Net
The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites…

The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a phase 2 study for its adjuvanted recombinant protein-based COVID-19 vaccine candidate.
Our research team at GW is proud to play a role in testing COVID-19 vaccine candidates to help end one of the greatest public health challenges of our time. We know that in order to end this pandemic, we’ll need more than…
Continue Reading